30 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
10 Nov 21
Maravai Lifesciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance for 2022
4:09pm
and Community Relations. The full report is available on the Investor Relations section of the Maravai website at: https://investors.maravai.com/esg
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
for mRNA Medicines (AMM). With the founding of the Alliance for mRNA Medicines, our community is now poised to champion scientific standards and public
S-8
EX-10.2
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
23 Nov 20
Registration of securities for employees
5:06pm
of such Participant’s death prior to exercise of the Participant’s rights under the Plan. If the Participant is married and resides in a community
S-1/A
EX-10.11
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Nov 20
IPO registration (amended)
2:05pm
prior to exercise of the Participant’s rights under the Plan. If the Participant is married and resides in a community property state, a designation
S-1/A
EX-10.8
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Nov 20
IPO registration (amended)
2:05pm
of an act of the Agent or a TRA Holder in violation of this Agreement) or is generally known to the business community and (ii) the disclosure
8-K
EX-10.1
myuro5
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-1
EX-10.16
dv0yrq qx0i74o8
29 Oct 20
IPO registration
5:04pm
DRS/A
EX-10.16
mq1qqb 5v
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.18
eeutaljxtsm
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.18
o31rwnx
29 Oct 20
IPO registration
5:04pm
PRE 14A
7enzfuap9yb
9 Apr 21
Preliminary proxy
4:16pm
DEF 14A
twyjbqt ra4xmat32es4
19 Apr 21
Definitive proxy
4:46pm
424B4
hpc7cfkqutrcry5xi
13 Sep 21
Prospectus supplement with pricing info
4:16pm
424B4
d58tup2bwo1 6be
23 Nov 20
Prospectus supplement with pricing info
4:36pm
DRS/A
2fyrzslp
14 Oct 20
Draft registration statement (amended)
12:00am
DRS
4vb vffe4
8 Sep 20
Draft registration statement
12:00am